Search Within

Cailian Liu

Formats
  1. Journal Article (31)
  2. Meeting Abstract (29)
Groups
  1. Department of Medicine (60)
  2. Solid Tumor Oncology Division (60)
  3. GSK Faculty (59)
  4. Melanoma and Immunotherapeutics Service (59)
  5. Sloan Kettering Institute Postdocs (46)
  6. Sloan Kettering Institute Faculty (22)

More Groups

People
  1. Jedd Wolchok (56)
  2. Taha Merghoub (49)
  3. Sadna Budhu (30)
  4. Hong Zhong (19)
  5. Roberta Zappasodi (19)
  6. Daniel Hirschhorn Cymerman (16)

More People

Years
  1. 2024 (1)
  2. 2022 (6)
  3. 2021 (5)
  4. 2020 (7)
  5. 2019 (3)
  6. 2018 (11)

More Years

Publications
  1. Cancer Research (12)
  2. Journal for ImmunoTherapy of Cancer (11)
  3. Cancer Cell (4)
  4. Cancer Immunology Research (4)
  5. Journal of Immunology (3)
  6. Blood (2)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. Biomed Central Ltd (11)
  3. Nature Publishing Group (8)
  4. Cell Press (7)
  5. Elsevier Inc. (3)
  6. The American Association of Immunologists, Inc (3)

More Publishers

Results (60)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
    Journal Article

    Memon, D.; Schoenfeld, A. J.; Ye, D.; Fromm, G.; Rizvi, H.; Zhang, X.; Keddar, M. R.; Mathew, D.; Yoo, K. J.; Qiu, J.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Signal-regulatory protein alpha (SIRPα) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Apr-246 induces an increase in tumor immunogenicity in a p53 independent manner
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Lu, C.; Budhu, S.; George, M.; Ouerfelli, O.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Potential role of CD47 in T cell exhaustion program
    Meeting Abstract

    Weng, C. H.; Samaan, F.; Budhu, S.; Mangarin, L.; Monette, S.; Liu, C.; Pourpe, S.; Hamadene, L.; Zhong, H.; Yang, X.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • APR-246 enhances tumor immunogenicity even in the absence of p53
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Liu, C.; Budhu, S.; George, M. M.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
    Journal Article

    Hirschhorn, D.; Betof Warner, A.; Maniyar, R.; Chow, A.; Mangarin, L. M. B.; Cohen, A. D.; Hamadene, L.; Rizzuto, G. A.; Budhu, S.; Suek, N.; more...
    JCI Insight (2021)

    Fulltext@MSK | Save
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save